Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Eli Lilly

Eli Lilly reported $18.88B in Loan Capital for its fiscal quarter ending in March of 2023.

Loan Capital Change
Abbott ABT:US USD 14.62B 93M
Amgen AMGN:US USD 60.76B 23.41B
AstraZeneca AZN:LN USD 27.65B 3.96B
Baxter International BAX:US USD 15.28B 46M
Biogen BIIB:US USD 6.28B 1.7M
Catalent CTLT:US USD 4.22B 123M
Drreddys Laboratories RDY:US INR 1.28B 179M
Eli Lilly LLY:US USD 18.88B 4.14B
Endo International ENDP:US USD 7.69B 7.69B
GlaxoSmithKline GSK:LN GBP 16.64B 391M
Glaxosmithkline GSK:US GBP 16.64B 391M
Horizon Pharma HZNP:US USD 2.54B 2.61M
Intercept Pharmaceuticals ICPT:US USD 223.35M 248K
J&J JNJ:US USD 34.93B 8.04B
Novartis NOVN:VX USD 21.99B 203M
Novartis NVS:US USD 21.99B 203M
Perrigo PRGO:US USD 4.06B 7.6M
Phibro Animal Health PAHC:US USD 466.02M 5.21M
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Revance Therapeutics RVNC:US USD 379.86M 485K
Roche Holding ROG:VX 21.39B 978M
United Therapeutics UTHR:US USD 800M 0
Zoetis ZTS:US USD 6.56B 7M